7835 Everbright Health-CH: Correction Announced for Auditor Opinion Type and Disclosure Notes in 115 Q2 Consolidated Financial Report

Release Date: 1150816 Statement Date: 1150815 Statement Time: 15245 Company Code: 7835 Company Name: Everbright Health-CH Subject: Announcement of Correction to Auditor Opinion Type and Disclosure Notes in the 115 Q2 Consolidated Financial Report iXBRL Compliance Clause: Item 51 Factual Date: 1150814

Details: 1. Factual Date: 115/08/14 2. Company Name: Everbright Health Co., Ltd. 3. Relationship with Company (Enter '本公司' or 'Subsidiary'):本公司 4. Cross-shareholding Ratio: Not applicable 5. Reason for Occurrence: (1) Correction of auditor opinion type in the 115 Q2 consolidated financial report iXBRL (2) Correction of disclosure notes in the 115 Q2 financial report announcement 6. Items/Report Names to be Corrected: (1) 115 Q2 Consolidated Financial Report - Auditor's Review Report (2) 115 Q2 Financial Report Announcement Notes 7. Information Before Correction/Content/Page: (1) 115 Q2 Consolidated Financial Report - Auditor's Review Report - Qualified Conclusion (Other) (2) The Company's financial statements for the second quarter of 115 have been approved by the Board of Directors and reviewed by Ms. Lien Chan-Nu and Mr. Cheng Yu-Jen, certified public accountants of PricewaterhouseCoopers Taiwan, in accordance with the Rules for Auditing and Certification of Financial Statements and Generally Accepted Auditing Standards, issuing a qualified conclusion review report. 8. Information After Correction/Content/Page: (1) 115 Q2 Consolidated Financial Report - Auditor's Review Report - Qualified Conclusion (Non-material Subsidiaries or Equity-method Investments Not Reviewed by Auditor) (2) The Company's 115 Q2 consolidated financial report has been reviewed by Ms. Lien Chan-Nu and Mr. Cheng Yu-Jen, certified public accountants of PricewaterhouseCoopers Taiwan. As the financial statements of non-material subsidiaries and equity-method investments included in the consolidated financial statements, along with related disclosures in Note 13, were not reviewed by the auditors, a qualified conclusion review report has been issued. The aforementioned audited consolidated financial report has been approved by the Company's Board of Directors and Audit Committee. 9. Response Measures: After releasing the material information, re-upload to the Public Information Observation System. 10. Other Matters to be Disclosed: None